Intramyocardial hydrogel injection is an innovative and promising treatment for myocardial
infarction (MI) and has recently entered clinical trials. By providing mechanical support to the …

Intramyocardial injection of various injectable hydrogel materials has shown benefit in
positively impacting the course of left ventricular (LV) remodeling after myocardial infarction …

A recent trend has emerged that involves myocardial injection of biomaterials, containing
cells or acellular, following myocardial infarction (MI) to influence the remodeling response …

Introduction: Heart failure following myocardial infarction (MI) impacts millions of people
each year in the US. The field of tissue engineering has developed several potential …

Cardiac tissue damage due to myocardial infarction (MI) is one of the leading causes of
mortality worldwide. The available treatments of MI include pharmaceutical therapy, medical …

Background—Injectable, acellular biomaterials hold promise to limit left ventricular
remodeling and heart failure precipitated by infarction through bulking or stiffening the infarct …

Biomaterials are increasingly being investigated as a means of reducing stress within the
ventricular wall of infarcted hearts and thus attenuating pathological remodelling and loss of …

Injectable hydrogels are being developed as potential translatable materials to influence the
cascade of events that occur after myocardial infarction. These hydrogels, consisting of both …

New therapies are needed to prevent heart failure after myocardial infarction (MI). As
experimental treatment strategies for MI approach translation, safety and efficacy must be …

Expansion of myocardium after myocardial infarction (MI) has long been identified as the
primary mechanism that drives adverse left ventricular (LV) remodeling towards heart failure …